Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer (clinicaltrials.gov) - Oct 14, 2026 - P2 | N=10 | Suspended | Sponsor: Emory University | Trial completion date: Jun 2028 ➔ Jun 2029 | Trial primary completion date: Jun 2027 ➔ Jun 2028
Trial completion date • Trial primary completion date • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
|